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Abstract: Introduction: Lupus erythematosus is a multisystemic disease that is characterized by autoantibody 
production and immune complex deposition in such tissues as the mucosa, joints, the central nervous system, 
and skin. Cutaneous lupus erythematosus is categorized as acute, subacute, and chronic. Chronic cutaneous lu-
pus erythematosus comprises discoid lupus erythematosus (DLE) and lupus profundus (LP). Aim: To analyze the 
expression of proapoptotic molecules in patients with lupus erythematosus discoid and lupus profundus. Material 
and methods: Descriptive study, the study groups comprised 10 cases of LP and 10 cases of DLE, and a control. Skin 
samples of cases and controls were processed for immunohistochemistry and by TUNEL technique. The database 
and statistical analysis was performed (statistical test X2) SPSS (Chicago, IL, USA). Results: Apoptotic features were 
broadly distributed along the skin biopsies in epidermal keratinocytes as well as at dermis. By immunohistochemistry 
the expression of Fas receptor and Fas-L was higher in the skin of lupus patients compared with controls. We also 
noted differences in Fas-L, -Fas, and -Bax proteins expression intensity in discoid lupus erythematosus patients in 
the epidermis, and hair follicles. Conclusions: Fas and Fas-L are expressed similarly in LP and DLE.
Keywords: Apoptosis, discoid lupus, lupus profundus, chronic cutaneous lupus erythematosus, proapoptotic mol-
ecules
Introduction
Lupus erythematosus (LE) is a multisystemic 
disease that is characterized by autoantibody 
production and immune complex deposition in 
such tissues as the mucosa, joints, the central 
nervous system, and skin. Its diagnosis and 
classification is based on clinical and serologi-
cal correlation [1].
Cutaneous lupus erythematosus (CLE) is cate-
gorized as acute, subacute, and chronic [2-4]. 
Chronic cutaneous lupus erythematosus 
(CCLE) comprises discoid lupus erythematosus 
(DLE) and lupus profundus (LP) [5]. 
DLE is the most common type of CLE, affecting 
the face, scalp, ears, neck, and the extensor 
surfaces of thoracic limbs [6]. DLE occurs in 
women of reproductive age (20-40 years), rang-
ing in prevalence from 14.6 to 68 per 100,000 
cases of lupus, and the number of diagnosed 
cases is expected to increase due to the devel-
opment of new biomarkers that can be used to 
diagnose the disease.
Systemic lupus erythematosus (SLE) is more 
common in women and has no predilection for 
any race [7]; the diagnostic criteria of the 
American College of Rheumatology for SLE 
include malar rash; discoid rash; photosensitiv-
ity; oral ulcers; arthritis; serositis; renal, neuro-
logical, hematological, and immunological dis-
orders; and the presence of antinuclear anti-
bodies [8].
In most frequent dermatological consultations 
of CLE cases correspond to DLE and LP, both 
dermatologic features display lower morbidity 
and mortality that the SLE, in this the quality of 
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life is practically limited to physical ap- 
pearance.
Five percent of patients with DLE progress to 
SLE that tends to be less aggressive than in 
those in whom systemic disease begins abrupt-
ly [9, 10].
This condition develops in genetically suscepti-
ble subjects who are exposed to environmental 
factors, such as UV radiation, infection, and 
drugs, which accelerate progression of the dis-
ease [11].
The clinical presentation consists of erythema, 
hyper- or hypopigmentation, plaques, and atro-
phy [4, 5]. LP is characterized by an inflamma-
tory infiltrate in the subcutaneous tissue and 
deep dermis, manifesting clinically as erythe-
ma with subcutaneous nodules and an ery-
thematous surface or fovea when the evolution 
is chronic.
Local skin damage due to physical, chemical, 
and biological factors (eg, environmental, infec-
tious, hormonal, and stress-related) induces 
apoptosis, in which antigens and intracellular 
molecules translocate in the cell surface [6]. 
Apoptosis is an active form of programmed cell 
death in response to external or internal molec-
ular signals and is detected directly and indi-
rectly. TUNEL (transferase-mediated dUTP nick-
end labeling) is a direct method, whereas 
immunohistochemistry is an indirect approach, 
in which the expression of molecules that regu-
late apoptosis is analyzed, such as Fas, Fas-L, 
Bax, Bcl-2, and p53 [12].
The aim of this study was to analyze the expres-
sion of proapoptotic molecules in patients with 
lupus erythematosus discoid and lupus profun-
dus, this is of importance because its clinical 
implication in skin regeneration and reparative 
process in lupus profundus. 
Material and methods
This descriptive study was conducted at the 
Department of Dermatology of General Hospital 
“Dr. Manuel Gea González” and in the 
Department of Immunology of the Universidad 
Autónoma de Zacatecas. (Approved by the eth-
ics committee and research of the General 
Hospital “Dr. Manuel Gea González” #06-40-
2011). Patients signed informed consent for 
diagnosis and treatment.
The study groups comprised 10 cases of LP 
and 10 cases of DLE, and a control (healthy tis-
sue without histological alteration).
Skin samples of cases and controls were pro-
cessed for immunohistochemistry (IHC). Two-
micrometer-thick sections were deparaffinized 
for 10 minutes at 60°C and hydrated in xylene 
and an alcohol series (100%, 95%, and 70%). 
After being washed with 1X phosphate-buff-
ered saline (PBS) for 5 minutes, they were heat-
ed for 1 minute in citrate buffer, pH 6 for anti-
gen retrieval, and endogenous peroxidase was 
blocked for 10 minutes with 3% H2O2 dissolved 
in metanol. 
The tissues were incubated for 18 hours at 4°C 
in a moist chamber with monoclonal anti-Fas-L. 
(®RDI-CD95Lamb. RDI Flanders, NJ, USA), anti-
body -Fas (DAKO) and anti-Bax (®RDI-BAX-
amb-A7 RDI Flanders, NJ, USA), diluted 1:100. 
Then, the sections were incubated with HRP-
conjugated anti-mouse IgG (Cat. 50695148 
Zymed San Francisco, California) for 4 h and 
washed twice with PBS for 5 minutes. The color 
reaction was induced by 3,3’-diaminobenzi-
dine-0.06% H2O2 (Sigma, St Louis, MO), and the 
reaction was stopped with 0.5 M sulfuric acid, 
and counterstained with hematoxylin for 1 min-
ute. After a dehydration step in alcohol, the 
specimens were cleared with xylene and 
mounted in synthetic resin for microscopy 
(Olympus B-Max BX-40) at 20X and 40X.
The analysis was performed by 2 investigators 
whom examined the tissues in a blinded man-
ner, ten random fields were tested to determine 
the bit rates of immunoreactivity. The images 
were analyzed with Image-Pro Plus, Version 7.0 
for WindowsTM. 
Apoptosis was measured by DNA fragmenta-
tion with an apoptosis detection kit (Roche 
TUNEL-Apo-AP; Cat 11684795910 Penzberg, 
Germany). Tissues were deparaffinized and 
hydrated as in the IHC experiments. After being 
washed in PBS for 5 minutes, the sections were 
incubated with TUNEL mixture for 1 hour at 
37°C in the dark.
The samples were washed in PBS and mounted 
in fluorescence mounting medium (Dako, Cat. 
S3023, Dakocytomation), for analysis at 20X 
and 40X under a fluorescence microscope 
(Olympus B-Max BX-40). 
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To distinguish apoptotic and nonapoptotic sam-
ples, cells were counterstained with propidium 
iodide. As a positive control for the TUNEL stain-
ing, a sample was treated with DNase-1 for 30 
minutes, and the negative control was incubat-
ed with labeling solution without enzyme.
The database and statistical analysis was per-
formed (statistical test X2) SPSS (Chicago, IL, 
USA).
Results
Apoptotic features were broadly distributed 
along the skin biopsies in epidermal keratino-
cytes as well as at dermis. By immunohisto-
chemistry the expression of Fas receptor and 
Fas-L was higher in the skin of lupus patients 
compared with controls. We also noted differ-
ences in Fas-L, -Fas, and -Bax proteins expres-
sion intensity in DLE patients in the epidermis, 
and hair follicles, as well as long inflammatory 
infiltrates of DLE and other groups of lupus (X2 
= 11.000 P = 0.027) (Table 1).
Discussion
By present studies we demonstrated the pres-
ence of increased apoptosis in lupus deter-
mined by TUNEL and immunohistochemistry 
technique. The pathophysiology of lupus ery-
thematosus is complex-in addition to apoptotic 
factors, the lack of elimination of apoptotic 
debris likely effects the production of autoanti-
bodies against intracellular molecules, such as 
anti-DNA [13].
Table 1. Expression of proapoptotic molecules 
DLE LP
Antibody Location Intensity % Location Intensity %
Fas-L Epidermis Mild 70 Epidermis Mild 40
Moderate 20 Moderate 50
Severe 10 Severe 10
Hair follicle Mild 40 Hair follicle Mild 30
Moderate 50 Moderate 60
Severe 10 Severe 10
Inflammatory infiltrate Mild 70 Inflammatory infiltrate Mild 90
Moderate 30 Severe 10
Fas Epidermis Mild 70 Epidermis Mild 70
Moderate 30 Moderate 30
Hair follicle Negative 10 Hair follicle Negative 10
Mild 60 Mild 60
Moderate 30 Moderate 30
Inflammatory infiltrate Mild 70 Inflammatory infiltrate Negative 10
Moderate 30 Mild 70
Moderate 20
Bax Epidermis Mild 50 Epidermis Mild 70
Moderate 50 Moderate 20
Severe 10
Hair follicle Mild 40 Negative 10
Moderate 40 Hair follicle Mild 70
Severe 10 Moderate 10
Severe 10
Inflammatory infiltrate Mild 40 Inflammatory infiltrate Negative 10
Moderate 40 Mild 70
Severe 10 Moderate 10
Severe 10
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Apoptosis is physiologically programmed cell 
death that can be initiated by a permanently 
active mechanism (extrinsic pathway) or by 
irreparable DNA damage due to external fac-
tors (intrinsic pathway).
Apoptosis begins in the membrane with a sig-
nal that is induced by cellular damage and by 
the binding of ligands to their receptors and is 
characterized by the loss of membrane integri-
ty [14, 15]. 
The extrinsic pathway of apoptosis is effected 
by cytokine receptors and ligands from the 
tumor necrosis factor family. Fas-L and Fas 
receptor mediate immune regulation and the 
development of autoimmunity, and mutations 
in Fas and its ligand cause severe lymphade-
nopathy and autoimmunity in humans and 
mice. The function of Fas-L is to stimulate Fas 
receptor on the cell membrane, initiating signal 
transduction and activating caspases [16].
Fas receptor triggers apoptosis [17] and has 
other nonapoptotic signaling functions that are 
poorly understood, such as in extracellular sig-
naling, invasion, and cell proliferation [18].
Based in our findings, the Fas-L and its Fas 
receptor are expressed at similar levels in LP 
and DLE (mild to moderate), our findings are 
consistent with other authors that demonstrat-
ed increased activity of the extrinsic apoptotic 
pathway. 
Bax is a proapoptotic member of the Bcl-2 fam-
ily that regulates intrinsic apoptotic signaling 
[19]. Bax is expressed in the cytoplasm in an 
inactive form and is activated in the early stag-
es of apoptosis. It is associated with mitochon-
dria through poorly understood mechanisms 
and induces conformational changes [20].
Ohsako et al. studied SLE activity, reporting sig-
nificant expression of Bcl2 and Bax in cases of 
Figure 1. TUNEL staining of lupus profundus (400 ×). A. Positivity in the epidermis. B. Reaction in the hair follicle and 
adjacent lymphocytic infiltrate. C. Control. D. Control +.
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active versus inactive disease. This group also 
discussed the hypothesis of Oltvai, in which 
overexpression of Bax accelerates cell death 
and proposed that the anti-Bcl2 and -Bax can 
be used as indicators of the rate of programmed 
cell death [21].
We found that the protein Bax is expressed in 
the DLE in the epidermis, hair follicle, and 
inflammatory infiltrate at mild to moderate lev-
els, and in LP, the intensity rose slightly in 70% 
of cases, regardless of histological localization. 
The increased intensity of Bax in DLE with 
respect to LP is likely to be associated with 
greater apoptosis.
Faurschou et al., measured the level of renal 
cell apoptosis in biopsies from 35 patients with 
lupus nephritis by TUNEL staining and observed 
positive tubular cells and high levels of mono-
nuclear tubule interstitial infiltration in a cohort 
of patients with SLE, indicating that the level of 
apoptosis in tubular cells is linked to the sever-
ity of inflammation in this type of lupus [22].
In our study, we noted 100% TUNEL positivity in 
DLE and LP; in DLE, the intensity was severe in 
60% and mild in 40% of cases, versus 80% and 
20% in LP, respectively. Thus, we infer that 
there is greater apoptotic activity in LP, similar 
to the results of Faurschou, who also use 
TUNEL, although we analyzed skin, whereas 
they studied kidney.
Our results are consistent with Chong et al., 
who also demonstrated the presence of apop-
tosis in the epidermis of cutaneous lupus by 
TUNEL. Nevertheless, they failed to note any 
positivity in LP, whereas our results were simi-
lar in DLE and DL.
In LP patients, Fas-L and Bax expression dif-
fered in the epidermis and inflammatory infil-
trate (X2 = 13.571 P = 0.009). With regards to 
apoptotic features, all DLE and LP cases dis-
play positive TUNEL meanwhile in the healthy 
controls the TUNEL tag was irrelevant (Figure 
1). The distribution of apoptotic cells in DLE 
samples occurred in the epidermis, hair follicle, 
and inflammatory infiltrates. In conclusion, Fas 
and Fas-L are expressed similarly in LP and 
DLE.
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